Login

AVEO PHARMACEUTICALS, INC. 3 SEC Filings

Filed On Filing
03 Dec 2021 Form 3: Ledell Jebediah, Chief Operating Officer

No securities owned

27 Apr 2021 Form 3: Cullen Kevin Joseph, Director

No securities owned

24 Mar 2021 Form 3: Ferraresso Michael, Chief Commercial Officer

Holds 3,284 shares of Common Stock

08 Jan 2021 Form 3: Epperly Corinne, Director

No securities owned

08 Jan 2020 Form 3: Lucera Erick, Chief Financial Officer

No securities owned

20 Nov 2019 Form 3: Spring Scarlett, Director

No securities owned

01 Mar 2019 Form 3: Mayes, Gregory T., Director

No securities owned

28 Jun 2018 Form 3: Makhzoumi Mohamad, 10% owner

Holds 17,591,297 shares of Common Stock

28 Jun 2018 Form 3: Puttagunta Chetan, 10% owner

Holds 17,591,297 shares of Common Stock

05 Feb 2018 Form 3: Rubin Karuna, Senior VP and General Counsel
05 Feb 2018 Form 3: Johnson John, Director

No securities owned

22 Nov 2017 Form 3: Mehta Nikhil, See Remarks

No securities owned

08 Jun 2017 Form 3: Dallas Matthew D, Chief Financial Officer

No securities owned

17 May 2016 Form 3: Weller Harry R, 10% owner

Holds 10,362,694 shares of Common Stock

17 May 2016 Form 3: Viswanathan Ravi, 10% owner

Holds 10,362,694 shares of Common Stock

17 May 2016 Form 3: Sonsini Peter W., 10% owner

Holds 10,362,694 shares of Common Stock

17 May 2016 Form 3: Sandell Scott D, 10% owner

Holds 10,362,694 shares of Common Stock

17 May 2016 Form 3: Sakoda Jon, 10% owner

Holds 10,362,694 shares of Common Stock

17 May 2016 Form 3: Mott David M, 10% owner

Holds 10,362,694 shares of Common Stock

17 May 2016 Form 3: Makower Joshua, 10% owner

Holds 10,362,694 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support